Health

Employees jump at genetic testing. is usually in which a Great thing?

Levi Strauss & Company introduced a novel benefit for employees at its San Francisco headquarters last fall: free genetic screening to assess their hereditary risks for certain cancers in addition to high cholesterol. Chip Bergh, Levi’s chief executive, said he had hoped in which the tests might spur employees to take preventive health steps in addition to in in which ...

Read More »

Philip Morris shares slide after PMI says iQOS growth in Japan slows

Philip Morris International shares plummeted 16 percent within the company’s worst day since of which spun off through Altria in 2008, after PMI posted mixed first-quarter results in addition to said growth of iQOS, its heat-not-burn tobacco product, slowed in Japan. iQOS warms tobacco to a temperature of which’s high enough to emit an aerosal yet not high enough to ...

Read More »

Cannabis-derived drug clears hurdle on path to FDA approval

A drug designed to combat seizures in children with severe epilepsy has been approved by an outside panel of advisors to the FDA, a major milestone on the way to full approval. Epidiolex would certainly be the first drug derived coming from cannabis on the U.S. market. The panel of 13 advisors concluded of which the benefit-risk profile of Epidiolex ...

Read More »

Synthego helping scientists use CRISPR to edit genes

Biology is usually undergoing a huge shift, as researchers today have a completely new tool to alter our genetic code. Advances in a technology called CRISPR — which stands for Clustered Regularly Interspaced Short Palindromic Repeats — give scientists something like a pair of “scissors,” so they can snip away at genetic material with the goal of treating disease, growing ...

Read More »

You’re part of the problem

Drugmakers may not be the only ones keeping less-expensive drugs off the market. The Food along with Drug Administration has approved nine biosimilars, generic versions of biologic medicines, however only three are available inside U.S. Manufacturers are using several schemes to “hamstring biosimilar competition,” FDA Commissioner Scott Gottlieb said at the Pharmaceutical Care Management Association’s PBM Policy Forum, according to ...

Read More »

AI pharma start-up BenevolentAI worth $2 billion after funding round

British artificial intelligence start-up BenevolentAI has bagged $115 million through investors, lifting its pre-money valuation to $2 billion. The London-based firm, which is usually focused on the pharmaceutical industry, said the latest round of funding will help the idea scale drug development in addition to its AI platform. The company currently has more than 20 drug programs. the idea said ...

Read More »

Comcast along with Independence Health to partner on fresh health care platform

Comcast is actually teaming up with one of the nation’s largest Blue Cross health insurers, Independence Health Group, to launch a fresh consumer-oriented health-care technology platform. “Through This specific collaboration, we will explore how we can best use technology to enhance how consumers access along with use healthcare services, which we know at times can be frustrating,” said Daniel J. ...

Read More »

How doctors from the US prescribe opioids — four charts

The number of patients getting brand new prescriptions for opioids — defined as those who haven’t been prescribed one from the previous year — declined by 7.8 percent in 2017. brand new prescription starts, particularly for chronic pain, can be a key indicator of future opioid use, Iqvia said. The decline can be attributed to a few reasons, according to ...

Read More »